About this role
The business development team at ONT is responsible for building an ecosystem of business partnerships to accelerate the adoption of nanopore sequencing in applied and clinical markets and generate medium- and long-term revenue for the company. The role of Director, Corporate Business Development (Infectious Disease) is primarily focused on developing partnerships with companies who are aiming to develop and commercialise applications of nanopore sequencing in strategically prioritised clinical applied and industrial end markets.